Pfizer receives orphan drug status for GL-2045 to treat CIDP

Pfizer has received orphan drug designation from the US Food and Drug Administration (FDA) for the autoimmune candidate GL-2045.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news